b'Gel and Capillary Gel and CapillaryResearch Use Only (RUO) Assay Invivoscribe offers an array of assays forB- and T-cell gene clonality/rearrangements, B-Cell AssaysT-Cell AssaysTranslocation Assays mutations, and chromosome translocations for 96/ IGH + IGK B-Cell 106/ TCRB Gene 114/ BCL1/J HTranslocationClonality Assays Clonality AssaysAssay the study of hematologic malignancies.98/ IGH Gene Rearrangement108/ T-Cell Receptor Gama116/ BCL2/J Ht(14;18) AssaysGene Rearrangement Assays 2.0 Translocation Assay These (RUO) assays are available for either ABI capillary electrophoresis 100/ IGH Gene Clonality110/ T-Cell Receptor Gama118/ BCL2/J HTranslocation fluorescence, or PAGE/agarose gel detection, and contain the PCR master Assays Gene Rearrangement Assays Assaymixes, recommended controls, and Instructions For Use. 102/ IGK Gene Clonality 112/ TCRD Gene 120/ BCR/ABL t(9;22) Translocation On the following pages, you will find detailed information on each RUO assay, including: assay use, background Assays Clonality Assays Assays information, typical output data, kit contents, and ordering information. These assays are available in regular 104/ IGL Gene Clonality 122/ PML/RAR t(15;17)sizes (30 or 33 reactions). Select assays are also available in high-volume MegaKit formats (300 or 330 Assays Translocation Assays reactions).These pages contain Research Use Only products which are not for use in diagnostic procedures.Research Use Only (RUO) assays are not for sale in Europe and other global markets where equivalent CE-IVD assays Mutation Assays are available and registered with the appropriate regulatory agencies. Refer to the preceding pages for information regarding our IdentiClone and LeukoStrat CE-IVD Assays.124/ IGH Somatic Hypermutation For more information, please visit www.invivoscribe.comAssays v2.0 126/ FLT3 MutationAssaysWARRANTY AND LIABILITYInvivoscribe, Inc. (Invivoscribe) is committed to providing the highest quality products. Invivoscribe warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe. Invivoscribe liability shall not exceed the purchase price of the product. Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchasers laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of positive, negative, and blank controls every time a sample is tested. Ordering, acceptance, and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.NOTICE: Many of these products in the section that follows are covered by one or more of the following: European Patent Number 1549764, European Patent Number 2418287, European Patent Number 2460889, Japanese Patent Number 4708029, United States Patent 8859748, United States Patent 10280462, and related pending and future applications.All of these patents and applications are licensed exclusively to Invivoscribe, Inc.Additional patents licensed to Invivoscribe covering some of these products apply elsewhere.These products require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). No license under these patents to use amplification processes or enzymes is conveyed expressly or by implication to the purchaser by the purchase of these products.Invivoscribe 2021|95'